NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 389 filers reported holding NOVAVAX INC in Q1 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,203 | -1.3% | 1,133 | +1.3% | 0.00% | – |
| Q2 2023 | $8,307 | +11.0% | 1,118 | +3.5% | 0.00% | – |
| Q1 2023 | $7,484 | +25.5% | 1,080 | +86.2% | 0.00% | – |
| Q4 2022 | $5,962 | +98.7% | 580 | +231.4% | 0.00% | – |
| Q3 2022 | $3,000 | -76.9% | 175 | -30.0% | 0.00% | – |
| Q2 2022 | $13,000 | -51.9% | 250 | -31.3% | 0.00% | -100.0% |
| Q1 2022 | $27,000 | -46.0% | 364 | +3.7% | 0.00% | -50.0% |
| Q4 2021 | $50,000 | -23.1% | 351 | +12.5% | 0.00% | 0.0% |
| Q3 2021 | $65,000 | +103.1% | 312 | +103.9% | 0.00% | +100.0% |
| Q2 2021 | $32,000 | +23.1% | 153 | +4.8% | 0.00% | 0.0% |
| Q1 2021 | $26,000 | +160.0% | 146 | +62.2% | 0.00% | – |
| Q4 2020 | $10,000 | -9.1% | 90 | -8.2% | 0.00% | -100.0% |
| Q3 2020 | $11,000 | +266.7% | 98 | +164.9% | 0.00% | – |
| Q2 2020 | $3,000 | – | 37 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |